CRE Testimony Highlights CMS’ Lack of Transparency, Inability to Manage Competitive Bidding Programs

The Center for Regulatory Effectiveness informed the House Subcommittee on Health’s hearing on “Medicare’s Competitive Bidding Program for Durable Medical Equipment: Implications for Quality, Cost and Access” about issues including:

• The belief by many American seniors that the competitive bidding program reflected a lack of concern about their well-being by our nation’s leadership;
• CMS’ repeated refusal to adhere to statutory transparency requirements; and
• Critical failings in CMS management of other competitive bidding efforts that halted those programs.

Tozzi Testimony